共 57 条
MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
被引:280
作者:
Dudda, Jan C.
[1
]
Salaun, Bruno
[1
]
Ji, Yun
[2
]
Palmer, Douglas C.
[2
]
Monnot, Gwennaelle C.
[1
]
Merck, Estelle
[1
]
Boudousquie, Caroline
[1
]
Utzschneider, Daniel T.
[4
]
Escobar, Thelma M.
[3
]
Perret, Rachel
[1
]
Muljo, Stefan A.
[3
]
Hebeisen, Michael
[1
,5
]
Rufer, Nathalie
[1
,5
]
Zehn, Dietmar
[4
]
Donda, Alena
[1
]
Restifo, Nicholas P.
[2
]
Held, Werner
[1
]
Gattinoni, Luca
[2
]
Romero, Pedro
[1
]
机构:
[1] Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland
[2] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
[3] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
[4] Univ Lausanne Hosp, Swiss Vaccine Res Inst, CH-1011 Lausanne, Switzerland
[5] Univ Lausanne Hosp, Dept Res, CH-1011 Lausanne, Switzerland
来源:
基金:
瑞士国家科学基金会;
关键词:
CHRONIC VIRAL-INFECTION;
IMMUNE-SYSTEM;
CYTOKINE SIGNALING-1;
B-CELL;
DIFFERENTIATION;
EXPRESSION;
ANTIGEN;
MEMORY;
PERSISTENCE;
ACTIVATION;
D O I:
10.1016/j.immuni.2012.12.006
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) T cell immunity remains unknown. Here we report that miRNA-155 is required for CD8(+) T cell responses to both virus and cancer. In the absence of miRNA-155, accumulation of effector CD8(+) T cells was severely reduced during acute and chronic viral infections and control of virus replication was impaired. Similarly, Mir155(-/-) CD8(+) T cells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response. miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5. Consistently, enforced expression of SOCS-1 in CD8(+) T cells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction. These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) T cells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.
引用
收藏
页码:742 / 753
页数:12
相关论文